巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    虛擬市場

    Achieve Life Sciences

    ACHV
    6.770
    ▲0.060
    ▲0.89%
    概況消息
    最少15分鐘延遲，股票資訊由第三方資訊供應商提供
    ・Achieve Life Sciences - 延遲價格・最後更新於 23/05 12:14
    最高位
    6.790
    最低位
    6.700
    開市價
    --
    前收市價
    6.710
    成交量(千)
    0.43
    成交額(百萬)
    0.02
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    65.55
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    10.090 - 5.621
    所有資料不保證絕對正確、完整、或實時，僅作為參考使用。投資涉及風險，過往業績並不代表將來表現，作任何投資決定或交易前，閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Achieve Life Sciences
    證券代碼
    ACHV.US
    所屬板塊
    Biotechnology
    公司業務
    Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline.
    發行量
    9460835
    公司總部
    22722 29th Drive Southeast, Suite 100
    公司網址
    https://www.achievelifesciences.com
    公司電郵
    sspecht@oncogenex.com
    公司電話
    +1 425 686-1500

    最新發佈

    暫無內容

    關於

    Achieve Life Sciences(ACHV.US)所屬的行業板塊為Biotechnology。
    Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline.
    詳細公司背景可參考: https://www.achievelifesciences.com。